Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Shockwave therapy could ease lipedema symptoms in new trial

NCT ID NCT07240415

First seen Nov 20, 2025 · Last updated Jun 23, 2026 · Updated 23 times

Summary

This study tests whether adding shockwave therapy to standard care (like compression and massage) can reduce pain and swelling in women with lipedema. Fifty women aged 18-65 with early-stage lipedema will be randomly assigned to receive either standard care alone or standard care plus shockwave therapy twice a week for four weeks. Researchers will measure changes in limb size, pain, and quality of life over eight weeks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIPEDEMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

radial extracorporeal shockwave therapy (ESWT)

What this could lead to

If it works, this could offer a new, non-invasive option to ease pain and improve quality of life for women with lipedema.

What could go wrong

This is a small, early-stage trial with only 50 people. The shockwave therapy may not provide significant extra benefit over standard care, and results may not apply to all lipedema patients.

Conditions

The condition(s) this trial relates to.

Chronic Pain Lipedema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.